Bundle-Branch Block

2

Review clinical trials related to Bundle-Branch Block. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up

The goal of this observational post-market clinical Follow-up study is to learn about the long-term safety, performance, and clinical benefits of pacing the left bundle branch area (LBBAP) using the INGEVITY+ pacemaker lead in patients with bradycardia who need a pacemaker.

Participants needed: 140
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Boston Scientific CorporationUpdated: Jun 4, 2026Locations: 13Duration: 3 Years
Eligibility criteria

Subjects intended to undergo initial (de novo) pacing system implant using the I... [+11]

Subjects meeting guideline indications for cardiac resynchronization therapy (CR... [+10]

Status: Recruiting

ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing

The goal of this observational study is to evaluate the clinical characteristics of patients undergoing permanent cardiac pacing and to compare procedural efficacy and safety of different implantation approaches in the clinical practice of the participating centres. The contribution of non-fluoroscopic anatomical and electrophysiological reconstruction systems to device implantation procedures will also be evaluated. Participants \[patients over 18 years old with an indication to receive a definitive pacemaker/intracardiac defibrillator implant\] will receive a permanent cardiac pacing implant as requested according to European Society of Cardiology (ESC) guidelines; the investigators will evaluate procedural efficacy and safety of different implantation approaches.

Participants needed: 8,400
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital of FerraraUpdated: Mar 22, 2024Locations: 31
Eligibility criteria

Indication for cardiac stimulation [+1]

Age < 18 years; [+1]